4//SEC Filing
CLARKE JOHN K 4
Accession 0001209191-22-026084
CIK 0001339970other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 7:39 PM ET
Size
5.6 KB
Accession
0001209191-22-026084
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Restricted Stock Units
2022-04-26+6,000→ 6,000 total→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001219015
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 7:39 PM ET
- Size
- 5.6 KB